Although the alleviation of disease symptoms with anti-BAFF therapy underscored the importance of BAFF in SLE pathogenesis, the contribution of individual receptors to BAFF action is poorly understood. The gene discussed is TNFSF13B; the disease is systemic lupus erythematosus.